Table 4.
Cost of monitoring for VTE/SPAF for patients on warfarin, enoxaparin, dabigatran or rivaroxaban
| Warfarin 5mg Once Daily (n=39) | Dabigatran 220mg Once Daily | Rivaroxaban 10mg Once Daily | ||||
|---|---|---|---|---|---|---|
| Cost of Monitoring | INR26 | ALT26, ! | ALT26, ! | |||
| VTE | SPAF | VTE | SPAF | VTE | SPAF | |
| No. of tests conducted during admission (SD) | 3.23 (1.44) | 3.71 (1.59) | 2 | 2 | 2 | 2 |
| Cost of test per day (AUD) | 13.80 | 13.80 | 9.75 | 9.75 | 9.75 | 9.75 |
| Cost per patient (AUD) | 44.57 | 51.20 | 9.75 | 9.75 | 9.75 | 9.75 |
!
The initial ALT test was not included in the cost analysis since the it is conducted as routine in every patient that is admitted